Showing results (41-50 of 47) with videos related to
Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 47 results.
Molecular Cancer Therapeutics|July 21, 2018
Cabozantinib Exhibits Potent Antitumor Activity in Colorectal Cancer Patient-Derived Tumor Xenograft Models via Autophagy and Signaling MechanismsAaron J Scott, John J Arcaroli, Stacey M Bagby, et al.International Journal of Cancer|September 23, 2014
Potent antitumor activity of cabozantinib, a c-MET and VEGFR2 inhibitor, in a colorectal cancer patient-derived tumor explant modelEun-Kee Song, W M Tai, Wells A Messersmith, et al.Oncotarget|July 8, 2016
Antitumor activity of the aurora a selective kinase inhibitor, alisertib, against preclinical models of colorectal cancerTodd M Pitts, Erica L Bradshaw-Pierce, Stacey M Bagby, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 13, 2013
Rational combination of a MEK inhibitor, selumetinib, and the Wnt/calcium pathway modulator, cyclosporin A, in preclinical models of colorectal cancerAnna Spreafico, John J Tentler, Todd M Pitts, et al.International Journal of Cancer|July 9, 2015
A NOTCH1 gene copy number gain is a prognostic indicator of worse survival and a predictive biomarker to a Notch1 targeting antibody in colorectal cancerJohn J Arcaroli, W M Tai, Ryan McWilliams, et al.Journal of the National Cancer Institute|September 17, 2016
Regulation of Head and Neck Squamous Cancer Stem Cells by PI3K and SOX2Stephen B Keysar, Phuong N Le, Bettina Miller, et al.Molecular Oncology|April 24, 2013
A patient tumor transplant model of squamous cell cancer identifies PI3K inhibitors as candidate therapeutics in defined molecular binsStephen B Keysar, David P Astling, Ryan T Anderson, et al.Pageof 5